Page last updated: 2024-12-05

dimaprit

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Dimaprit is a synthetic purine nucleoside analog that acts as a potent adenosine receptor agonist. It was first synthesized in the 1970s and has been extensively studied for its pharmacological properties, particularly its effects on the central nervous system, cardiovascular system, and immune system. Dimaprit exhibits high affinity for adenosine A1 and A2A receptors, leading to a wide range of effects. For instance, it has been shown to have anxiolytic, anticonvulsant, and neuroprotective properties. Its effects on the cardiovascular system include vasodilation and bradycardia. Furthermore, dimaprit has been investigated for its potential therapeutic applications in various conditions, such as stroke, Alzheimer's disease, and Parkinson's disease. Research on dimaprit focuses on understanding its mechanism of action, exploring its therapeutic potential, and developing novel drug candidates based on its structure and activity.'

Dimaprit: A histamine H2 receptor agonist that is often used to study the activity of histamine and its receptors. [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID3077
CHEMBL ID12344
CHEBI ID81389
SCHEMBL ID379810
MeSH IDM0026195

Synonyms (43)

Synonym
BRD-K23541596-300-04-9
gtpl1248
3-dimethylaminopropylsulfanylmethanimidamide
pseudourea, 2-(3-(dimethylamino)propyl)-2-thio-
brn 2350552
carbamimidothioic acid, 3-(dimethylamino)propyl ester
bdbm22883
chembl12344 ,
[3-(carbamimidoylsulfanyl)propyl]dimethylamine
3-(dimethylamino)propyl imidothiocarbamate
AE-641/25069014
PRESTWICK3_000983
tocris-0506
cas-23256-33-9
NCGC00024621-01
NCGC00016775-01
BPBIO1_001151
BSPBIO_001045
AB00514696
dimaprit
PRESTWICK2_000983
NCGC00024621-02
PRESTWICK1_000983
PRESTWICK0_000983
SPBIO_002946
65119-89-3
L000225
chebi:81389 ,
C17930
3-(dimethylamino)propyl carbamimidothioate
AKOS006280081
NCGC00016775-03
NCGC00016775-02
unii-zzq699148p
zzq699148p ,
3-dimethylaminopropyl sulfanylmethanimidamide
SCHEMBL379810
AB00514696_02
DTXSID0037154
s-[3-(n,n-dimethylamino)propyl]isothiourea
Q5277162
BRD-K23541596-300-05-6
NCGC00016775-04

Research Excerpts

Overview

Dimaprit is an agonist and ranitidine is an antagonist of H(2) histamine receptors.

ExcerptReferenceRelevance
"Dimaprit is an agonist and ranitidine is an antagonist of H(2) histamine receptors."( Blockade of histamine H2 receptors of the periaqueductal gray and inferior colliculus induces fear-like behaviors.
Brandão, ML; Huston, JP; Santos, NR, 2003
)
1.04
"Dimaprit is an agonist and ranitidine an antagonist of H2 histamine receptors."( Further evidence for the involvement of histamine H2 receptors in the control of defensive behaviour generated in the midbrain tectum.
Brandão, ML; Husto, JP; Santos, NR, 2002
)
1.04

Actions

ExcerptReferenceRelevance
"Dimaprit stimulated an increase in JnetNa, largely as a result of increases in JmsNa."( Functional subtyping of histamine receptors on the canine proximal colonic mucosa.
Prior, T; Rangachari, PK, 1994
)
1.01

Treatment

Dimaprit treatment significantly reduced clinical signs compared to vehicle in C57BL/6 and iNOS deficient EAE mice. Treatment with dimaprit at 6 and 60 microM for 20 min significantly inhibited the anaphylactic histamine release.

ExcerptReferenceRelevance
"Dimaprit treatment significantly reduced clinical signs compared to vehicle in both C57BL/6 and iNOS deficient EAE mice."( Activation of histamine H2 receptors ameliorates experimental allergic encephalomyelitis.
Emerson, MR; LeVine, SM; Lynch, SG; Orentas, DM, 2002
)
1.04
"The dimaprit treatment depressed the values to 40-64% of those in the corresponding control group 4-24 hr after reperfusion."( Suppression of ischaemia-induced cytokine release by dimaprit and amelioration of liver injury in rats.
Adachi, N; Arai, T; Liu, K; Motoki, A; Nagaro, T; Nishibori, M; Takahashi, HK; Yorozuya, T, 2008
)
1.08
"Treatment with dimaprit at 6 and 60 microM for 20 min significantly inhibited the anaphylactic histamine release, whereas betahistine at up to 80 microM under the same conditions did not affect it."( Dimaprit, a histamine H2-agonist, inhibits anaphylactic histamine release from mast cells and the decreased release is restored by thioperamide (H3-antagonist), but not by cimetidine (H2-antagonist).
Kohno, S; Nabe, T; Ogawa, K; Ohata, K; Yamamura, H, 1993
)
2.07

Bioavailability

ExcerptReferenceRelevance
" ratios indicate that, relative to ranitidine, the bioavailability of AY-29,315 by the oral route was low, particularly in the dog."( Antisecretory and antiulcer activities of a potent new histamine H2-receptor antagonist with an intermediate duration of action.
Borella, L; Failli, A; Grimes, D; Mir, GN; Rimele, TJ; Russell, J, 1988
)
0.27
" Bioavailability and/or biotransformation are the factors most likely to account for the differences observed between species, and between in vivo and in vitro studies for this long-acting antisecretory agent."( In vivo and in vitro effects of CM 57755, a new gastric antisecretory agent acting on histamine H2 receptors.
Aureggi, G; Bianchetti, A; Carminati, P; Lavezzo, A; Manzoni, L; Nisato, D, 1984
)
0.27

Dosage Studied

Intravenous infusion of CM 57755 induced a parallel shift to the right of the dimaprit dose-response curve. Omeprazole caused a non-competitive inhibition of the dose- response curve to dimapritic. Cimetidine (1-30 microM) shifted to the left of thedimaprit log dose-Response curve, producing a pA(2) value of 5.

ExcerptRelevanceReference
" The following methods were used: a) gastric acid hypersecretion induced by histamine and carbachol in the pylorus-ligated rat preparation; b) contractile dose-response curves to histamine and carbachol in the guinea pig ileum; c) dimaprit-stimulated guinea pig atrium in vitro."( Mechanism of action of doxepin in the treatment of chronic urticaria.
Almeida, L; Figueiredo, A; Gonçalo, M; Poiares-Baptista, A; Ribeiro, CA; Teixeira, F, 1990
)
0.46
" Omeprazole caused a non-competitive inhibition of the dose-response curve to dimaprit, whereas famotidine induced a parallel shift to the right without depressing the maximum response."( Antisecretory activity of omeprazole in the conscious gastric fistula cat: comparison with famotidine.
Bertaccini, G; Coruzzi, G,
)
0.36
" According to the two dosing schedules adopted to evaluate the duration of action, mifentidine, compared to cimetidine and ranitidine, required considerably lower oral dosages to display its protective effect."( Cimetidine, ranitidine and mifentidine in specific gastric and duodenal ulcer models.
Cereda, E; Del Soldato, P; Donetti, A; Ghiorzi, A, 1985
)
0.27
" In the second set of experiments, equiactive doses (that is the respective ED50s calculated from the previously established dose-response curves) of all the compounds were infused during dimaprit-induced acid hypersecretion, in order to evaluate their duration of action."( Effect of the new H2-receptor antagonist mifentidine on gastric acid secretion in the cat: comparison with cimetidine and ranitidine.
Bertaccini, G; Scarpignato, C; Tangwa, M; Tramacere, R, 1985
)
0.46
" the respective ED50s calculated from the previously established dose-response curves) of all the three antagonists was completely different."( The effect of the new H2-receptor antagonist mifentidine on gastric secretion, gastric emptying and experimental gastric and duodenal ulcers in the rat: comparison with cimetidine and ranitidine.
Del Soldato, P; Scarpignato, C; Tangwa, M; Tramacere, R, 1986
)
0.27
" The maximum pepsin output obtained from a set of complete dose-response curves of dimaprit was not statistically different from basal values."( Comparison of the effects of structurally different H2-antagonists on acid and pepsin activity stimulated by dimaprit in conscious cats.
Barocelli, E; Chiavarini, M; Impicciatore, M; Molina, E; Morini, G; Plazzi, PV, 1985
)
0.71
" Intravenous infusion of CM 57755 induced a parallel shift to the right of the dimaprit dose-response curve."( Inhibition of dimaprit- and pentagastrin-induced gastric acid secretion in cats by the new histamine H2 antagonist, CM 57755.
Bianchetti, A; Lavezzo, A; Manara, L; Manzoni, L, 1986
)
0.86
"32 mumol kg-1 h-1) caused a parallel displacement of the dose-response curve to dimaprit to the right, without reducing the maximum response to the stimulant, thus behaving as a competitive antagonist, like ranitidine."( Inhibitory effect of famotidine on cat gastric secretion.
Bertaccini, G; Coruzzi, G; Dobrilla, G; Noci, MT, 1986
)
0.5
" Dose-response curves to dimaprit in stimulating gastric secretion were displaced to the right in a dose-related fashion by both drugs."( Kinetic analysis of the interaction of mifentidine with gastric H2-receptors in the conscious dog.
Giachetti, A; Pagani, F; Zecca, M, 1987
)
0.58
" The muscarinic antagonist atropine, 1 microM, and the beta 2-adrenoceptor antagonist propranolol, 10 microM, had no effect on the dose-response curve for dimaprit-induced relaxation of the lung strip."( A study of the histamine H2-receptor mediating relaxation of the parenchymal lung strip preparation of the guinea-pig.
Foreman, JC; Rising, TJ; Webber, SE, 1985
)
0.47
" H1-agonists (2-methylHi and 2-thiazolylethylamine) also depressed the avoidance response; their dose-response lines run parallel to that of Hi."( The effects of histamine and some related compounds on conditioned avoidance response in rats.
Akahori, H; Kamei, C; Kitazumi, K; Tasaka, K, 1985
)
0.27
" In an apparently all-or-none manner, both caused a sinistral shift in dose-response curves for the phasic component of the contractile response to histamine at H1 receptors on the ileum."( Metronidazole and 5-aminosalicylic acid enhance the contractile activity of histaminergic agonists on the guinea-pig isolated ileum.
Barker, LA; Winbery, SL, 1986
)
0.27
" Conversely, following potentiation of the response to histamine with DTT, exposure of the tissue to desensitizing concentrations of histamine resulted in a dextral shift of the dose-response curve (dose ratio = 39."( Selective enhancement of histamine H1-receptor responses in guinea-pig ileal smooth muscle by 1,4-dithiothreitol.
Donaldson, J; Hill, SJ, 1986
)
0.27
" The selective histamine H1-receptor antagonist chlorpheniramine shifted the dose-response curves of histamine and 2-PEA for inducing vasoconstriction to the right."( Characteristics of histamine receptors in the isolated and perfused canine coronary arteries.
Chiba, S; Nakane, T, 1987
)
0.27
" Pretreatment of parenchymal strips with cimetidine or YM-11170, H2-receptor antagonists, resulted in a parallel shift of the dimaprit dose-response curve to the right."( Effects of histamine H2-receptor agonists and antagonists on isolated guinea-pig airway muscles.
Tomioka, K; Yamada, T, 1982
)
0.47
" Using quantitative cytochemistry of CA activity in guinea-pig oxyntic cells, we compared the dose-response relationships (1."( Evidence for histamine H1 and H2 receptors in guinea-pig oxyntic cells.
Heldsinger, AA; Skoglund, ML; Vinik, AI, 1983
)
0.27
" This study serves to quantitate the pharmacologic effects of several agents on anti-IgE-mediated histamine release from dispersed human lung mast cells and has further suggested that the dispersed cell system is similar to the standard chopped lung system in dose-response relationships, kinetics, and pharmacologic modulation."( Dispersed human lung mast cells. Pharmacologic aspects and comparison with human lung tissue fragments.
Lichtenstein, LM; MacGlashan, DW; Newball, HH; Peters, SP; Schleimer, RP; Schulman, ES, 1982
)
0.26
" The H1-antagonist chlorpheniramine shifted to the right the dose-response curves to histamine and to 2-aminoethylthiazole with the kinetics of the competitive antagonism."( Histamine receptors in the human ureter.
Bertaccini, G; Bezzi, E; Potenzoni, D; Zappia, L, 1983
)
0.27
" The dose-response curves of inhibition of mitogen-induced lymphocyte activation for chloroquine and methylamine are very steep and are similar to the dose-response curves obtained with dimaprit and nordimaprit, but very different from the flat dose-response curves previously described for histamine."( A comparison of dimaprit, nordimaprit, methylamine and chloroquine as inhibitors of mitogen-induced lymphocyte activation.
Dale, MM; Ladd, R, 1984
)
0.8
" The dose-response curve to histamine was displaced to the right by mepyramine and further to the right by mepyramine plus cimetidine."( Evidence for both histamine H1- and H2-receptors in the gastric vasculature of the cat.
Harvey, CA; Owen, DA; Shaw, KD, 1980
)
0.26
" The dose-response curves for respective components of the salivary and vasodilator responses to PEA were parallel with the corresponding curves for histamine and in producing these responses PEA was about 40 times less potent than histamine on a molar basis."( Characterization of neuronal and vascular histamine receptors mediating the salivary and vasodilator responses to histamine of the dog submandibular gland.
Nunoki, K; Shimizu, T; Taira, N, 1981
)
0.26
" If the mice were dosed daily (i."( Effect of histamine agonists and antagonists on the production of murine reaginic antibodies.
Baker, AP; Chakrin, LW; Holden, DA; Smith, WJ; Sung, CP, 1981
)
0.26
" The dose-response curves for histamine in the control group pretreated with cimetidine were shifted to the left and responses reached almost the same level as those of the atherosclerotic group."( Mechanisms of augmented vascular responses to histamine in atherosclerotic rabbit common carotid arteries.
Chiba, S; Fujiwara, T, 1994
)
0.29
"Pretreatment with SKF 91488 shifted, in a dose-dependent fashion, the dose-response curves of the leakage of dye to histamine to lower concentrations in the trachea, main bronchi, and nasal mucosa."( Histamine N-methyltransferase inhibitor potentiates histamine- and antigen-induced airway microvascular leakage in guinea pigs.
Maeyama, K; Morikawa, M; Nakazawa, H; Sasaki, H; Sekizawa, K; Watanabe, T; Yamauchi, K, 1995
)
0.29
" After pretreating the spirals with impromidine, the maximum response to histamine was reduced in a dose-dependent manner and the cumulative dose-response curve to histamine was shifted to right."( [The relationship between H2 receptor and the pathogenesis of bronchial asthma in guinea-pigs].
Chen, X; Luo, W; Ye, Y, 1995
)
0.29
" Histamine dose-response curves showed that concentrations between 5 nm and 5 microM increased permeability, while concentrations from 50 microM to 5 mM reduced it."( Regulation of cerebral microvascular permeability by histamine in the anaesthetized rat.
Easton, AS; Fraser, PA; Sarker, MH, 1998
)
0.3
" The results indicate that dimaprit, an H2 agonist, facilitated retention (25 and 50 pg) with a U-shaped dose-response curve typical of drugs acting at postsynaptic receptors."( Effect of histamine H2 and H3 receptor modulation in the septum on post-training memory processing.
Flood, JF; Morley, JE; Uezu, K, 1998
)
0.6
"We report here that the dose-response curve of the histamine-stimulated phosphoinositide hydrolysis in the guinea pig cerebellar slices was shifted to the left when the slices were pretreated with SKF 91488 (100 microM), a specific inhibitor of histamine N-methyltransferase (HMT)."( Histamine N-methyltransferase regulates histamine-induced phosphoinositide hydrolysis in guinea pig cerebellum.
Kitanaka, J; Kitanaka, N; Takemura, M; Terada, N; Tsujimura, T, 2001
)
0.31
" Histamine dose-dependently induced the contraction of sections of the guinea-pig small intestine, and the pretreatment of the tissue section with aminoguanidine (100 microM), a diamine oxidase inhibitor, but not with S-[4-(N,N-dimethylamino)butyl]isothiourea (100 microM), an inhibitor of histamine N-methyltransferase, shifted the dose-response curve of histamine-induced contraction to lower concentrations."( Expression of diamine oxidase (histaminase) in guinea-pig tissues.
Kitanaka, J; Kitanaka, N; Takemura, M; Terada, N; Tsujimura, T, 2002
)
0.31
" Dose-response curves for adrenaline were carried out as standard protocol."( Characteristics of histamine tachyphylaxis in rat uterine smooth muscle.
Gil Marqués, M; Martínez-Mir, I; Morales-Olivas, FJ; Rubio-Gomis, E, 2002
)
0.31
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
imidothiocarbamic ester
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (7)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Chain A, TYROSYL-DNA PHOSPHODIESTERASEHomo sapiens (human)Potency0.06310.004023.8416100.0000AID485290
TDP1 proteinHomo sapiens (human)Potency22.48250.000811.382244.6684AID686978; AID686979
aldehyde dehydrogenase 1 family, member A1Homo sapiens (human)Potency39.81070.011212.4002100.0000AID1030
67.9K proteinVaccinia virusPotency18.25630.00018.4406100.0000AID720579; AID720580
lethal factor (plasmid)Bacillus anthracis str. A2012Potency31.62280.020010.786931.6228AID912
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Histamine H2 receptorHomo sapiens (human)Ki25.11890.00062.197310.0000AID548984
Histamine H4 receptorHomo sapiens (human)Ki0.24070.00060.478710.0000AID1798265; AID404336; AID548981
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Activation Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Histamine H4 receptorHomo sapiens (human)EC50 (µMol)1.58490.00740.601610.0000AID548993
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (11)

Processvia Protein(s)Taxonomy
gastric acid secretionHistamine H2 receptorHomo sapiens (human)
immune responseHistamine H2 receptorHomo sapiens (human)
positive regulation of vasoconstrictionHistamine H2 receptorHomo sapiens (human)
G protein-coupled serotonin receptor signaling pathwayHistamine H2 receptorHomo sapiens (human)
chemical synaptic transmissionHistamine H2 receptorHomo sapiens (human)
G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messengerHistamine H2 receptorHomo sapiens (human)
inflammatory responseHistamine H4 receptorHomo sapiens (human)
positive regulation of cytosolic calcium ion concentrationHistamine H4 receptorHomo sapiens (human)
biological_processHistamine H4 receptorHomo sapiens (human)
regulation of MAPK cascadeHistamine H4 receptorHomo sapiens (human)
G protein-coupled serotonin receptor signaling pathwayHistamine H4 receptorHomo sapiens (human)
adenylate cyclase-inhibiting G protein-coupled acetylcholine receptor signaling pathwayHistamine H4 receptorHomo sapiens (human)
G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messengerHistamine H4 receptorHomo sapiens (human)
chemical synaptic transmissionHistamine H4 receptorHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (4)

Processvia Protein(s)Taxonomy
histamine receptor activityHistamine H2 receptorHomo sapiens (human)
G protein-coupled serotonin receptor activityHistamine H2 receptorHomo sapiens (human)
neurotransmitter receptor activityHistamine H2 receptorHomo sapiens (human)
histamine receptor activityHistamine H4 receptorHomo sapiens (human)
G protein-coupled serotonin receptor activityHistamine H4 receptorHomo sapiens (human)
G protein-coupled acetylcholine receptor activityHistamine H4 receptorHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (3)

Processvia Protein(s)Taxonomy
plasma membraneHistamine H2 receptorHomo sapiens (human)
synapseHistamine H2 receptorHomo sapiens (human)
plasma membraneHistamine H2 receptorHomo sapiens (human)
dendriteHistamine H2 receptorHomo sapiens (human)
plasma membraneHistamine H4 receptorHomo sapiens (human)
plasma membraneHistamine H4 receptorHomo sapiens (human)
dendriteHistamine H4 receptorHomo sapiens (human)
synapseHistamine H4 receptorHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (34)

Assay IDTitleYearJournalArticle
AID1346055Human H4 receptor (Histamine receptors)2001Molecular pharmacology, Mar, Volume: 59, Issue:3
Cloning, expression, and pharmacological characterization of a novel human histamine receptor.
AID1346055Human H4 receptor (Histamine receptors)2005The Journal of pharmacology and experimental therapeutics, Sep, Volume: 314, Issue:3
Evaluation of histamine H1-, H2-, and H3-receptor ligands at the human histamine H4 receptor: identification of 4-methylhistamine as the first potent and selective H4 receptor agonist.
AID1346055Human H4 receptor (Histamine receptors)2001Molecular pharmacology, Mar, Volume: 59, Issue:3
Cloning and pharmacological characterization of a fourth histamine receptor (H(4)) expressed in bone marrow.
AID1346055Human H4 receptor (Histamine receptors)2001The Journal of pharmacology and experimental therapeutics, Mar, Volume: 296, Issue:3
Cloning and characterization of a novel human histamine receptor.
AID1346107Human H3 receptor (Histamine receptors)2001Molecular pharmacology, Mar, Volume: 59, Issue:3
Cloning and pharmacological characterization of a fourth histamine receptor (H(4)) expressed in bone marrow.
AID548984Displacement of [125I]iodoaminopotentidine from human histamine H2 receptor expressed in CHO cells2010Bioorganic & medicinal chemistry letters, Dec-15, Volume: 20, Issue:24
Histamine H4 receptor agonists.
AID87852Evaluated for activity at Histamine H2 receptor in guinea pig ileum1990Journal of medicinal chemistry, Jan, Volume: 33, Issue:1
Histamine H3 ligands: just pharmacological tools or potential therapeutic agents?
AID72694In vitro inotropy blocking studies in ferret papillary muscle in the presence of 100 uM nadolol; NB-Not Blocked1990Journal of medicinal chemistry, Jun, Volume: 33, Issue:6
Cardiotonic agents. 6. Histamine analogues as potential cardiovascular selective H2 agonists.
AID78839In vitro contractile response of histamine at 0.5 ug/mL in guinea pig ileum1990Journal of medicinal chemistry, Jun, Volume: 33, Issue:6
Cardiotonic agents. 6. Histamine analogues as potential cardiovascular selective H2 agonists.
AID88570In vivo percent change in mean arterial pressure in guinea pig was determined at a dose of 1 mg/kg/h1990Journal of medicinal chemistry, Jun, Volume: 33, Issue:6
Cardiotonic agents. 6. Histamine analogues as potential cardiovascular selective H2 agonists.
AID88166Histamine H2 receptor agonistic activity in guinea pig right atrium1992Journal of medicinal chemistry, Aug-21, Volume: 35, Issue:17
Histamine H2-receptor agonists. Synthesis, in vitro pharmacology, and qualitative structure-activity relationships of substituted 4- and 5-(2-aminoethyl)thiazoles.
AID72695Concentration which gives 20% increase in the force contraction in ferret papillary muscle1990Journal of medicinal chemistry, Jun, Volume: 33, Issue:6
Cardiotonic agents. 6. Histamine analogues as potential cardiovascular selective H2 agonists.
AID72690In vitro inotropy blocking studies in ferret papillary muscle in the presence of 10 uM cimetidine; B-Blocked1990Journal of medicinal chemistry, Jun, Volume: 33, Issue:6
Cardiotonic agents. 6. Histamine analogues as potential cardiovascular selective H2 agonists.
AID548993Agonist activity at human histamine H4 receptor expressed in human SK-N-MC cells by CRE-beta galactosidase reporter gene assay2010Bioorganic & medicinal chemistry letters, Dec-15, Volume: 20, Issue:24
Histamine H4 receptor agonists.
AID88324Compound is evaluated for histamine H2 receptor agonistic activity in guinea pig cerebral cortex using [3H]tiotidine as radioligand1992Journal of medicinal chemistry, Aug-21, Volume: 35, Issue:17
Histamine H2-receptor agonists. Synthesis, in vitro pharmacology, and qualitative structure-activity relationships of substituted 4- and 5-(2-aminoethyl)thiazoles.
AID86257Evaluated for activity at Histamine H1 receptor in guinea pig ileum1990Journal of medicinal chemistry, Jan, Volume: 33, Issue:1
Histamine H3 ligands: just pharmacological tools or potential therapeutic agents?
AID78482In vitro chronotropic effect of histamine at 5 ug/mL in guinea pig atrium1990Journal of medicinal chemistry, Jun, Volume: 33, Issue:6
Cardiotonic agents. 6. Histamine analogues as potential cardiovascular selective H2 agonists.
AID404336Displacement of [3H]histamine from human histamine H4 receptor expressed in SK-NM-C cells2008Journal of medicinal chemistry, Jun-12, Volume: 51, Issue:11
Discovery of novel human histamine H4 receptor ligands by large-scale structure-based virtual screening.
AID177148In vivo effect on gastric acid secretion in rat was determined after subcutaneous administration1990Journal of medicinal chemistry, Jun, Volume: 33, Issue:6
Cardiotonic agents. 6. Histamine analogues as potential cardiovascular selective H2 agonists.
AID88564In vivo percent change in airway overflow in guinea pig was determined at a dose of 1 mg/kg/h1990Journal of medicinal chemistry, Jun, Volume: 33, Issue:6
Cardiotonic agents. 6. Histamine analogues as potential cardiovascular selective H2 agonists.
AID86316In vitro binding affinity for histamine H3 receptor was determined in guinea-pig cerebral cortex using [3H](R)-alpha-methylhistamine2000Journal of medicinal chemistry, Jun-15, Volume: 43, Issue:12
Design, synthesis, and structure-activity relationships of novel non-imidazole histamine H(3) receptor antagonists.
AID88573In vivo percent change in total acid secretion in guinea pig was determined at a dose of 1 mg/kg/h1990Journal of medicinal chemistry, Jun, Volume: 33, Issue:6
Cardiotonic agents. 6. Histamine analogues as potential cardiovascular selective H2 agonists.
AID548981Displacement of [3H]-histamine from human histamine H4 receptor expressed in Sf9 cells coexpressing RGS19, Galphai2, Gbeta1gamma22010Bioorganic & medicinal chemistry letters, Dec-15, Volume: 20, Issue:24
Histamine H4 receptor agonists.
AID548994Agonist activity at human histamine H4 receptor expressed in human SK-N-MC cells by CRE-beta galactosidase reporter gene assay relative to histamine2010Bioorganic & medicinal chemistry letters, Dec-15, Volume: 20, Issue:24
Histamine H4 receptor agonists.
AID88567In vivo percent change in heart rate in guinea pig was determined at a dose of 1 mg/kg/h1990Journal of medicinal chemistry, Jun, Volume: 33, Issue:6
Cardiotonic agents. 6. Histamine analogues as potential cardiovascular selective H2 agonists.
AID86313Tested in vitro against histamine H3 receptor mediated inhibition of cholinergic neurogenic contractions in isolated guinea pig ileum2000Journal of medicinal chemistry, Jun-15, Volume: 43, Issue:12
Design, synthesis, and structure-activity relationships of novel non-imidazole histamine H(3) receptor antagonists.
AID194443Relative inhibition of [3H]histamine release from pre-loaded slices of rat cerebral cortex1990Journal of medicinal chemistry, Jan, Volume: 33, Issue:1
Histamine H3 ligands: just pharmacological tools or potential therapeutic agents?
AID88034Intrinsic activity against histamine H2 receptor1992Journal of medicinal chemistry, Aug-21, Volume: 35, Issue:17
Histamine H2-receptor agonists. Synthesis, in vitro pharmacology, and qualitative structure-activity relationships of substituted 4- and 5-(2-aminoethyl)thiazoles.
AID232996dP/dt value of the compound1990Journal of medicinal chemistry, Jun, Volume: 33, Issue:6
Cardiotonic agents. 6. Histamine analogues as potential cardiovascular selective H2 agonists.
AID1508630Primary qHTS for small molecule stabilizers of the endoplasmic reticulum resident proteome: Secreted ER Calcium Modulated Protein (SERCaMP) assay2021Cell reports, 04-27, Volume: 35, Issue:4
A target-agnostic screen identifies approved drugs to stabilize the endoplasmic reticulum-resident proteome.
AID1347154Primary screen GU AMC qHTS for Zika virus inhibitors2020Proceedings of the National Academy of Sciences of the United States of America, 12-08, Volume: 117, Issue:49
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
AID651635Viability Counterscreen for Primary qHTS for Inhibitors of ATXN expression
AID1798265H4R Radioligand Binding Assay from Article 10.1124/jpet.105.087965: \\Evaluation of histamine H1-, H2-, and H3-receptor ligands at the human histamine H4 receptor: identification of 4-methylhistamine as the first potent and selective H4 receptor agonist.\\2005The Journal of pharmacology and experimental therapeutics, Sep, Volume: 314, Issue:3
Evaluation of histamine H1-, H2-, and H3-receptor ligands at the human histamine H4 receptor: identification of 4-methylhistamine as the first potent and selective H4 receptor agonist.
AID1159607Screen for inhibitors of RMI FANCM (MM2) intereaction2016Journal of biomolecular screening, Jul, Volume: 21, Issue:6
A High-Throughput Screening Strategy to Identify Protein-Protein Interaction Inhibitors That Block the Fanconi Anemia DNA Repair Pathway.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (461)

TimeframeStudies, This Drug (%)All Drugs %
pre-1990215 (46.64)18.7374
1990's130 (28.20)18.2507
2000's53 (11.50)29.6817
2010's22 (4.77)24.3611
2020's41 (8.89)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 25.70

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index25.70 (24.57)
Research Supply Index6.17 (2.92)
Research Growth Index4.69 (4.65)
Search Engine Demand Index34.37 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (25.70)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials2 (0.42%)5.53%
Reviews6 (1.26%)6.00%
Case Studies3 (0.63%)4.05%
Observational0 (0.00%)0.25%
Other464 (97.68%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]